Shares of Scancell Holdings Plc (LON:SCLP) passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $7.66 and traded as high as $8.37. Scancell shares last traded at $8.25, with a volume of 280,150 shares.
The business has a 50 day simple moving average of GBX 7.68. The firm has a market capitalization of $38.39 million and a P/E ratio of -5.50.
Scancell Company Profile (LON:SCLP)
Scancell Holdings plc engages in the discovery and development of novel monoclonal antibodies and vaccines for the treatment of cancer in the United Kingdom. The company's products include SCIB1, a plasmid DNA vaccine, which is in Phase I/II clinical trials for the treatment of melanoma; SCIB2 to treat lung cancer antigen; and Modi-1, which is in the pre-clinical development to treat triple negative breast cancer, ovarian cancer, and sarcoma.
See Also: Conference Calls and Individual Investors
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.